© 2020 lwebs.in
Drug major Cipla Wednesday reported over two-fold jump in consolidated
net profit to Rs 357.68 crore for the fourth quarter ended March 31,
mainly on account of robust sales across markets. In a separate filing, Cipla said its board has approved raising funds up to Rs 6,000 crore.